These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23341675)

  • 21. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.
    McFarlane SI; Jacober SJ; Winer N; Kaur J; Castro JP; Wui MA; Gliwa A; Von Gizycki H; Sowers JR
    Diabetes Care; 2002 Apr; 25(4):718-23. PubMed ID: 11919131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Compliance with the 2002 consensus document of the Spanish Society of Nephrology for the control of diabetic nephropathy in Catalonia (ECCODIAB)].
    Fontseré N; Bonal J; Torres F; de las Cuevas X; Fort J
    Nefrologia; 2006; 26(6):679-87. PubMed ID: 17227245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
    J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidimensional pharmacologic strategies for diabetes.
    Edmisson KW
    Nurs Clin North Am; 2005 Mar; 40(1):107-17. PubMed ID: 15733950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
    Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
    Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
    Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
    Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).
    Pagidipati NJ; Navar AM; Pieper KS; Green JB; Bethel MA; Armstrong PW; Josse RG; McGuire DK; Lokhnygina Y; Cornel JH; Halvorsen S; Strandberg TE; Delibasi T; Holman RR; Peterson ED;
    Circulation; 2017 Sep; 136(13):1193-1203. PubMed ID: 28626088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home.
    Joseph J; Koka M; Aronow WS
    J Am Med Dir Assoc; 2008 Jan; 9(1):51-4. PubMed ID: 18187113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertension and dyslipidemia treament in stroke].
    Nussbaumerová B
    Vnitr Lek; 2022; 68(3):172-177. PubMed ID: 36208947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.
    Pena-Polanco JE; Fried LF
    Semin Nephrol; 2016 Jul; 36(4):331-42. PubMed ID: 27475663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
    Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
    JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
    Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS).
    Zhang J; Shao Y; Liu Y; Tao J
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):581-589. PubMed ID: 30187345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015.
    Tabesh M; Magliano DJ; Tanamas SK; Surmont F; Bahendeka S; Chiang CE; Elgart JF; Gagliardino JJ; Kalra S; Krishnamoorthy S; Luk A; Maegawa H; Motala AA; Pirie F; Ramachandran A; Tayeb K; Vikulova O; Wong J; Shaw JE
    Diabet Med; 2019 Jul; 36(7):878-887. PubMed ID: 30402961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).
    Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group
    BMC Pediatr; 2009 Dec; 9():79. PubMed ID: 20017932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.